Recon: FDA issues EUA for Roche’s Actemra for severe COVID; EMA signs off on an additional manufacturing site for J&J vaccine
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesPharmaceuticalsReconMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesPharmaceuticals